SMTL ID : 6yw2.1

HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with bicyclic FG2216 and RaPID-derived cyclic peptide 3C (14-mer)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.14 Å

Oligo State

hetero-1-1-mer

Ligands

1 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 5 residues within 4Å: Chain A: H.139, D.141, F.192, H.200 Ligands: UN9.2 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.139, A:D.141, A:H.200, H2O.1

1 x UN9: N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE(Non-covalent)

UN9.2: 18 residues within 4Å: Chain A: G.64, D.80, I.82, M.125, A.127, Y.129, Y.136, H.139, D.141, I.153, Y.155, L.169, H.200, V.202, R.209, A.211, W.215 Ligands: MN.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.82, A:Y.136 Hydrogen bonds: A:Y.129, A:Y.155 Water bridges: A:T.213, A:T.213, A:T.213 Salt bridges: A:R.209

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chowdhury, R. et al., Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2. Sci Rep (2020)

Release Date

2020-12-30

Peptides

Egl nine homolog 1: A
PHD2-SPECIFIC RaPID CYCLIC PEPTIDE 3C (14-MER): B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Egl nine homolog 1

PHD2-SPECIFIC RaPID CYCLIC PEPTIDE 3C (14-MER)

Related Entries With Identical Sequence